We investigated the Pseudomonas aeruginosa (PA) outer membrane vesicles (OMVs) and
their effect on Acinetobacter baumannii (AB) growth in vitro. The inhibitory effects of PA on …

Tobramycin is commonly used to treat Pseudomonas aeruginosa lung infections in patients
with Cystic Fibrosis (CF). Tobramycin treatment leads to increased lung function and fewer …

Outer membrane vesicles (OMVs) are well-characterized virulence factors produced by
Gram-negative bacteria. Here, we isolated two clinical Acinetobacter baumannii strains, the …

Antimicrobial resistance (AMR) is a serious and most urgent global threat to human health.
AMR is one of today's biggest difficulties in the health system and has the potential to harm …

Acinetobacter baumannii is a major causative agent of nosocomial infections and its outer
membrane vesicles (AbOMVs) have been shown to be involved in pathogenicity by …

The pathogenicity of Pseudomonas aeruginosa gained from secreting virulence factors
called Outer membrane vesicles (OMVs), this study aimed to determine the concentration of …

The secretion of outer membrane vesicles (OMVs) is one of the major mechanisms by which
Gram-negative bacteria deliver effector molecules to host cells. Acinetobacter baumannii is …

Acinetobacter baumannii has emerged as an important opportunistic pathogen mostly
causing nosocomial infections. The virulence factors of this important pathogen are largely …

Acinetobacter baumannii is an important nosocomial pathogen that causes a high morbidity
and mortality rate in infected patients, but pathogenic mechanisms of this microorganism …

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that can cause acute
infections as well as chronic ones in humans. The expression of algD and PpyR genes …